Literature DB >> 31234648

Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP).

Xavier Rossello1,2, Jannick An Dorresteijn3, Arne Janssen4, Ekaterini Lambrinou4,5, Martijn Scherrenberg6,7, Eric Bonnefoy-Cudraz8, Mark Cobain9, Massimo F Piepoli10, Frank Lj Visseren2, Paul Dendale6,7.   

Abstract

Risk assessment have become essential in the prevention of cardiovascular disease. Even though risk prediction tools are recommended in the European guidelines, they are not adequately implemented in clinical practice. Risk prediction tools are meant to estimate prognosis in an unbiased and reliable way and to provide objective information on outcome probabilities. They support informed treatment decisions about the initiation or adjustment of preventive medication. Risk prediction tools facilitate risk communication to the patient and their family, and this may increase commitment and motivation to improve their health. Over the years many risk algorithms have been developed to predict 10-year cardiovascular mortality or lifetime risk in different populations, such as in healthy individuals, patients with established cardiovascular disease and patients with diabetes mellitus. Each risk algorithm has its own limitations, so different algorithms should be used in different patient populations. Risk algorithms are made available for use in clinical practice by means of - usually interactive and online available - tools. To help the clinician to choose the right tool for the right patient, a summary of available tools is provided. When choosing a tool, physicians should consider medical history, geographical region, clinical guidelines and additional risk measures among other things. Currently, the U-prevent.com website is the only risk prediction tool providing prediction algorithms for all patient categories, and its implementation in clinical practice is suggested/advised by the European Association of Preventive Cardiology.

Entities:  

Keywords:  Risk prediction; cardiovascular disease; patient; prevention; risk assessment

Year:  2019        PMID: 31234648     DOI: 10.1177/2047487319846715

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  16 in total

1.  Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review.

Authors:  Òscar Miró; Xavier Rossello; Elke Platz; Josep Masip; Danielle M Gualandro; W Frank Peacock; Susanna Price; Louise Cullen; Salvatore DiSomma; Mucio Tavares de Oliveira; John Jv McMurray; Francisco J Martín-Sánchez; Alan S Maisel; Christiaan Vrints; Martin R Cowie; Héctor Bueno; Alexandre Mebazaa; Christian Mueller
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2020-08

Review 2.  The Use of Aspirin in Contemporary Primary Prevention of Atherosclerotic Cardiovascular Diseases Revisited: The Increasing Need and Call for a Personalized Therapeutic Approach.

Authors:  Zlatko Fras; Amirhossein Sahebkar; Maciej Banach
Journal:  Am J Cardiovasc Drugs       Date:  2021-03       Impact factor: 3.571

3.  Improving 1-year mortality prediction in ACS patients using machine learning.

Authors:  Sebastian Weichwald; Alessandro Candreva; Rebekka Burkholz; Roland Klingenberg; Lorenz Räber; Dik Heg; Robert Manka; Baris Gencer; François Mach; David Nanchen; Nicolas Rodondi; Stephan Windecker; Reijo Laaksonen; Stanley L Hazen; Arnold von Eckardstein; Frank Ruschitzka; Thomas F Lüscher; Joachim M Buhmann; Christian M Matter
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2021-10-27

4.  Effects of Message Framing and Time Discounting on Health Communication for Optimum Cardiovascular Disease and Stroke Prevention (EMT-OCSP): a protocol for a pragmatic, multicentre, observer-blinded, 12-month randomised controlled study.

Authors:  Muke Zhou; Jian Guo; Ning Chen; Mengmeng Ma; Shuju Dong; Yanbo Li; Jinghuan Fang; Yang Zhang; Yanan Zhang; Jiajia Bao; Ye Hong; You Lu; Mingfang Qin; Ling Yin; Xiaodong Yang; Quan He; Xianbin Ding; Liyan Chen; Zhuoqun Wang; Shengquan Mi; Shengyun Chen; Cairong Zhu; Dong Zhou; Li He
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

5.  Engaging Female Community Health Volunteers (FCHVs) for cardiovascular diseases risk screening in Nepal.

Authors:  Lal B Rawal; Yuewen Sun; Padam K Dahal; Sushil C Baral; Sudeepa Khanal; Abriti Arjyal; Shraddha Manandhar; Abu S Abdullah
Journal:  PLoS One       Date:  2022-01-06       Impact factor: 3.240

6.  SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.

Authors: 
Journal:  Eur Heart J       Date:  2021-07-01       Impact factor: 35.855

7.  Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Retrospective Cohort.

Authors:  Eulalia Muria-Subirats; Josep Lluis Clua-Espuny; Juan Ballesta-Ors; Blanca Lorman-Carbo; Iñigo Lechuga-Duran; Jose Fernández-Saez; Roger Pla-Farnos
Journal:  Int J Environ Res Public Health       Date:  2020-05-16       Impact factor: 4.614

8.  Development and Validation of Decision Rules Models to Stratify Coronary Artery Disease, Diabetes, and Hypertension Risk in Preventive Care: Cohort Study of Returning UK Biobank Participants.

Authors:  José Castela Forte; Pytrik Folkertsma; Rahul Gannamani; Sridhar Kumaraswamy; Sarah Mount; Tom J de Koning; Sipko van Dam; Bruce H R Wolffenbuttel
Journal:  J Pers Med       Date:  2021-12-07

9.  Association Between Body Size Phenotypes and Subclinical Atherosclerosis.

Authors:  Xavier Rossello; Valentin Fuster; Belén Oliva; Javier Sanz; Leticia A Fernández Friera; Beatriz López-Melgar; José María Mendiguren; Enrique Lara-Pezzi; Héctor Bueno; Antonio Fernández-Ortiz; Borja Ibanez; José María Ordovás
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

10.  Validating World Health Organization cardiovascular disease risk charts and optimizing risk assessment in China.

Authors:  Jianxin Li; Fangchao Liu; Xueli Yang; Jie Cao; Shufeng Chen; Jichun Chen; Keyong Huang; Chong Shen; Xiaoqing Liu; Ling Yu; Yingxin Zhao; Xianping Wu; Liancheng Zhao; Xigui Wu; Ying Li; Dongsheng Hu; Jianfeng Huang; Xiangfeng Lu
Journal:  Lancet Reg Health West Pac       Date:  2021-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.